Rock Creek Pharmaceuticals Reports on Inhibition of STAT 3 Activation, A Key Marker of Inflammation, In Phase I Clinical Trial in Europe
Heliostar Metals to Present at the Precious Metals & Critical Minerals Virtual Investor Conference October 14
